Superinfection: Difference between revisions
No edit summary |
(No difference)
|
Revision as of 19:48, 25 February 2010
WikiDoc Resources for Superinfection |
Articles |
---|
Most recent articles on Superinfection Most cited articles on Superinfection |
Media |
Powerpoint slides on Superinfection |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Superinfection at Clinical Trials.gov Trial results on Superinfection Clinical Trials on Superinfection at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Superinfection NICE Guidance on Superinfection
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Superinfection Discussion groups on Superinfection Patient Handouts on Superinfection Directions to Hospitals Treating Superinfection Risk calculators and risk factors for Superinfection
|
Healthcare Provider Resources |
Causes & Risk Factors for Superinfection |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
In virology, superinfection is the process by which a cell that has previously been infected by one virus gets coinfected with another virus at a later point in time.
In medicine, superinfection is an infection following a previous infection, especially when caused by microorganisms that are resistant or have become resistant to the antibiotics used earlier.
Superinfection, according to Dorland's illustrated medical dictionary, is a condition produced by sudden growth of a type of bacteria, different from the original offenders in a wound or lesion under treatment.
Superinfection in Lambda phage
When a cell is a lambda lysogen, another lamda phage that infects is not able to undergo lytic development and produce phage. The incoming phage can inject DNA, however, the DNA is immediately shut down and no transcription/translation of the lambda initiates. Therefore, lambda lysogens are immune to infection by another lambda phage particle. The reason is because the lysogen is continuously producing cI repressor. The amount of cI protein exceeds the amount needed to shut down more than one phage. The extra repressor binds to the superinfecting phage DNA and prevents its transcription.